Abiopharma

News list

Shah Rutul R 🟡 adjusted position in 33.8K shares (1 derivative) of PRECIGEN, INC. (PGEN) at $6.50 Transaction Date: Aug 03, 2026 | Filing ID: 011711

Full text

News bot Aug. 3, 2026, 10:13 p.m.
🔍 Shah Rutul R (Executive)

Company: PRECIGEN, INC. (PGEN)

Report Date: 2026-08-03
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 33,772
- Total shares sold: 67,544
Detailed Transactions and Holdings:
- Acquired 33,772 shares of Common Stock at $2.33 per share (Direct)
  Date: 2026-08-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 531,523.00 | transaction_form_type: 4
- Sold 33,772 shares of Common Stock at $6.5 per share (Direct)
  Date: 2026-08-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 497,751.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 33,772 shares of Option to Purchase Common Stock (Right to Buy) at $2.33 per share (Derivative)
  Date: 2026-08-03 | Code: M | Expires: 2032-02-02 | equity_swap_involved: 0 | shares_owned_after: 123,304.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
- F2: The stock options are fully vested.